What are the indications for propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Propranolol is indicated for several cardiovascular and non-cardiovascular conditions, including hypertension, angina pectoris, arrhythmias, secondary prevention after myocardial infarction, migraine prophylaxis, essential tremor, and management of symptoms related to anxiety.

Indications for Propranolol

  • Hypertension
  • Angina pectoris
  • Arrhythmias (particularly supraventricular tachycardias)
  • Secondary prevention after myocardial infarction
  • Migraine prophylaxis
  • Essential tremor
  • Management of symptoms related to anxiety, particularly physical manifestations like palpitations and tremor
  • Portal hypertension to reduce the risk of variceal bleeding
  • Hypertrophic cardiomyopathy to control symptoms by reducing left ventricular outflow obstruction

Dosage and Administration

The medication works by blocking beta-adrenergic receptors, reducing heart rate, cardiac output, and blood pressure. Typical dosing ranges from 10-40 mg twice daily for anxiety symptoms to 80-320 mg daily for hypertension, with dosage adjustments based on patient response and condition being treated 1.

Contraindications

Propranolol is contraindicated in patients with:

  • Asthma
  • COPD
  • Bradycardia
  • Heart block
  • Cardiogenic shock
  • Uncontrolled heart failure due to its ability to block bronchodilation and reduce cardiac output 1.

Key Considerations

When initiating propranolol, it is essential to consider the patient's overall clinical condition, including the presence of any contraindications or potential interactions with other medications. The choice of beta blocker for an individual patient is based primarily on pharmacokinetic and side effect criteria, as well as on physician familiarity 1.

From the FDA Drug Label

Hypertension: Propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Angina Pectoris Due to Coronary Atherosclerosis: Propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine: Propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache Hypertrophic Subaortic Stenosis: Propranolol hydrochloride extended-release capsules improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.

The indications for propranolol are:

  • Hypertension: management of hypertension
  • Angina Pectoris: decrease angina frequency and increase exercise tolerance
  • Migraine: prophylaxis of common migraine headache
  • Hypertrophic Subaortic Stenosis: improve NYHA functional class in symptomatic patients 2

From the Research

Propranolol Indications

Propranolol is a beta-blocker with a wide range of indications, including:

  • Angina pectoris 3, 4, 5
  • Myocardial infarction 3, 4, 6
  • Hypertension 3, 4, 6
  • Cardiac dysrhythmias 3, 4
  • Hypertrophic subaortic stenosis 3
  • Migraine headache 3, 4, 7
  • Hyperthyroidism 3, 4
  • Pheochromocytoma 3, 4
  • Anxiety 4
  • Essential tremors 4, 6
  • Portal hypertension 4

Additional Considerations

When using propranolol, it is essential to consider the following:

  • The dosage of propranolol may need to be adjusted based on the individual patient's response to the medication 7, 5
  • Propranolol can be used in conjunction with other medications, such as antidepressants, without attenuating their therapeutic effects 6
  • Patients taking propranolol should be monitored for potential side effects, such as intolerable side effects that may intensify as the dose is increased 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertensive response to levonordefrin in a patient receiving propranolol: report of case.

Journal of the American Dental Association (1939), 1988

Research

Propranolol: A 50-Year Historical Perspective.

Annals of Indian Academy of Neurology, 2019

Research

Propranolol in the treatment of angina: a review.

Postgraduate medical journal, 1976

Research

The dose of propranolol for migraine prophylaxis. Efficacy of low doses.

Cephalalgia : an international journal of headache, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.